WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with co-pays on average less than $7 for 90% of drugs. But for a growing number of ...
Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...
The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...
Elizabeth Doran, a retired Canadian woman, says she has had to pick up extra teaching shifts to afford her semaglutide medication Elizabeth Doran has been taking GLP-1 medications for nearly a year ...
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin’s fish oil-derived cardiovascular drug Vascepa does not ...
Water exhibits a variety of anomalous behaviours. To date, many computer simulations and experimental studies have shown compelling evidence for the existence of a liquid–liquid phase transition ...
US Ambassador to India Sergio Gor expressed optimism over the proposed US-India trade agreement, saying the deal is expected to be signed in the coming weeks or months as negotiations enter their ...
Hosted on MSN
Why Canada has generic Ozempic, and the US doesn't
Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help reverse her prediabetes and high blood pressure. Because she had not yet developed diabetes, the retired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results